El Mundo

¿Vacuna contra el coronavirus a precio de costo? Tres laboratorios responden ‘no'

(FILES) In this file photo the Moderna headquarters is seen in Cambridge, Massachusetts on May 18, 2020. - Fresh hopes for a coronavirus vaccine and another round of US stimulus handed strong gains to most stock markets on July 15, 2020, although advances were tempered by the reimposition of lockdown measures, while China-US tensions weighed on Hong Kong and Shanghai. Investors took their lead from Wall Street's pop higher Tuesday, which came after US biotech firm Moderna said the final stage of human trials for a COVID-19 vaccine would start at the end of the month, after a report said first stage tests had been a success. (Photo by Joseph Prezioso / AFP)
(FILES) In this file photo the Moderna headquarters is seen in Cambridge, Massachusetts on May 18, 2020. - Fresh hopes for a coronavirus vaccine and another round of US stimulus handed strong gains to most stock markets on July 15, 2020, although advances were tempered by the reimposition of lockdown measures, while China-US tensions weighed on Hong Kong and Shanghai. Investors took their lead from Wall Street's pop higher Tuesday, which came after US biotech firm Moderna said the final stage of human trials for a COVID-19 vaccine would start at the end of the month, after a report said first stage tests had been a success. (Photo by Joseph Prezioso / AFP) JOSEPH PREZIOSO
‌
‌

‌

‌
‌

‌

‌